Freeport-McMoRan (FCX) is facing significant financial repercussions following a deadly mud rush at its Grasberg Block Cave mine in Indonesia, which accounts for approximately 70% of its copper and gold output through 2029. Scotiabank downgraded FCX to Sector Perform from Sector Outperform, cutting its price target to $45 from $55, citing extensive damage that will render production negligible in Q4 2025 and result in 2026 output being 35% below prior guidance, with normal rates not expected until 2027. This led to substantial cuts in 2025-26 EPS and EBITDA forecasts by an average of 27%, a 10% reduction in NAV, and projections for sharply weaker free cash flow, causing FCX shares to drop over 5%.
Freeport-McMoRan is confronting a significant operational and financial shock following a fatal mud rush at its Grasberg Block Cave (GBC) mine, a critical asset responsible for approximately 70% of the Grasberg complex's copper and gold output through 2029. The incident has prompted a material reassessment of the company's outlook by Scotiabank, which downgraded the stock to Sector Perform and cut its price target to $45 from $55. The analysis projects a severe production disruption, with GBC output expected to be negligible in Q4 2025 and 2026 production running 35% below prior guidance; a full return to normal rates is not anticipated until 2027. This operational impairment translates directly into sharp financial revisions, including an average 27% cut to 2025-26 EBITDA forecasts, a 10% reduction in net asset value to $19.15 per share, and significantly lower Adjusted EPS projections for 2025 ($1.29 vs. $1.68 prior) and 2026 ($1.16 vs. $1.65 prior). Consequently, free cash flow is expected to be sharply weaker through 2027, making a ramp-up in share buybacks unlikely until after 2026 and reflecting the market's immediate negative reaction, evidenced by a 5.51% drop in the share price.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
strongly negative
Sentiment Score
-0.75
Ticker Sentiment